This is a StreetInsider.com Premium Only Page

Catalyst Pharmaceuticals (CPRX) – StreetInsider.com Reports

Apr 2, 2024 10:00 AM Here are Oppenheimer’s best Smidcap ideas

Mar 14, 2024 05:06 AM Citi Starts Catalyst Pharmaceutical Partners (CPRX) at Buy

Mar 13, 2024 07:55 AM Catalyst Pharmaceuticals (CPRX) Announces AGAMREE Now Commercially Available in the US

Mar 7, 2024 09:33 AM BofA Securities Starts Catalyst Pharmaceutical Partners (CPRX) at Buy, 'undervalued biotech with key drug launch this year'

Mar 1, 2024 06:33 AM Catalyst Pharmaceutical Partners (CPRX) PT Raised to $34 at Cantor Fitzgerald

Feb 28, 2024 06:14 PM Catalyst Pharmaceuticals (CPRX) Tops Q4 EPS by 26c

Feb 21, 2024 09:00 AM Catalyst Pharmaceuticals (CPRX) Announces Publication of Santhera Pharmaceutical’s VISION-DMD Vamorolone Study Results in the Peer-Reviewed Journal Neurology

Jan 5, 2024 08:02 AM Catalyst Pharmaceuticals (CPRX) Prices 10M Share Offering at $15/sh

Jan 4, 2024 04:52 PM After-hours movers: Snowflake, Costco, and more

Jan 4, 2024 04:50 PM Catalyst Pharmaceuticals (CPRX) Announces Proposed $150M Share Offering

Dec 20, 2023 04:03 PM Oppenheimer Starts Catalyst Pharmaceutical Partners (CPRX) at Outperform, 'DMD Launch to Outpace Expectations'

Dec 18, 2023 06:32 AM Catalyst Pharmaceuticals (CPRX) Announces Submission of FIRDAPSE NDA in Japan by Partner DyDo Pharma

Dec 4, 2023 08:04 AM Catalyst Pharmaceuticals (CPRX) Announces Appointment of Michael W. Kalb as Chief Financial Officer and Other Executive Promotions

Nov 8, 2023 04:29 PM Catalyst Pharmaceuticals (CPRX) Tops Q3 EPS by 78c, Beats on Revenue; Offers FY23 Revenue Guidance

Nov 2, 2023 10:38 AM Catalyst Pharmaceuticals (CPRX) Receives Two New U.S. Patent Allowances For FIRDAPSE

Oct 27, 2023 05:22 AM Catalyst Pharmaceutical Partners (CPRX) PT Raised to $25 at Truist Securities

Oct 26, 2023 03:19 PM Catalyst Pharmaceuticals (CPRX) Reports FDA Approval of AGAMREE for Duchenne Muscular Dystrophy Granted to Santhera Pharmaceuticals

Oct 26, 2023 02:33 PM Catalyst Pharmaceuticals (CPRX) Halted, News Pending

Oct 19, 2023 08:04 AM Catalyst Pharmaceuticals (CPRX) Appoints Richard J. Daly as CEO

Oct 13, 2023 08:03 AM Catalyst Pharmaceuticals (CPRX) Announces FDA Acceptance of the Supplemental New Drug Application for FIRDAPSE

Sep 9, 2023 09:40 AM Catalyst Pharmaceuticals (CPRX) Files $500M Mixed Shelf

Aug 21, 2023 09:43 AM Catalyst Pharmaceutical Partners (CPRX) PT Raised to $15.50 at Roth/MKM

Aug 11, 2023 06:32 AM Catalyst Pharmaceutical Partners (CPRX) PT Raised to $27 at Cantor Fitzgerald

Aug 9, 2023 04:19 PM Catalyst Pharmaceuticals (CPRX) Tops Q2 EPS by 28c

Jul 25, 2023 08:05 AM Catalyst Pharmaceuticals (CPRX) Announces Upcoming CEO Retirement

Jul 19, 2023 06:00 AM Catalyst Pharmaceuticals (CPRX) Acquires Exclusive North American License For Vamorolone for Duchenne Muscular Dystrophy

Jun 20, 2023 11:45 AM Catalyst Pharmaceutical (CPRX) PT Raised to $24 at Truist Securities on Vamorolone opportunity

Jun 1, 2023 08:05 AM Catalyst Pharmaceuticals (CPRX) Reports Positive Momentum in Q2, Reaffirms FY Revenue Guidance

May 30, 2023 08:06 AM Catalyst Pharmaceuticals (CPRX) Appoints Tamar Thompson to its Board of Directors

May 16, 2023 03:26 AM Catalyst Pharmaceutical Partners (CPRX) PT Lowered to $15 at Roth/MKM

May 10, 2023 04:35 PM Catalyst Pharmaceuticals (CPRX) Tops Q1 EPS by 9c

May 9, 2023 08:03 AM Catalyst Pharmaceuticals (CPRX) Advances sNDA Submission Plans To Increase Indicated Maximum Dose For FIRDAPSE

Mar 17, 2023 06:36 AM Catalyst Pharmaceutical Partners (CPRX) PT Raised to $25 at Cantor Fitzgerald

Mar 15, 2023 04:13 PM Catalyst Pharmaceuticals (CPRX) Tops Q4 EPS by 11c; Offers Guidance

Mar 8, 2023 11:22 AM Catalyst Pharma (CPRX) Announces Recent Third-Party Publication Journal Epilepsia Showing Perampanel Demonstrated High Efficacy in Patients with Rare Genetic Epilepsies

Feb 7, 2023 08:20 AM Catalyst Pharmaceuticals (CPRX) Reports Preliminary Q4 Revenues , Provides FY23 Revenue Guidance

Jan 23, 2023 01:27 PM Catalyst Pharmaceuticals (CPRX) commented on the FDA's notice setting forth its position on Orphan Drug Exclusivity

Jan 23, 2023 08:14 AM Catalyst Pharmaceuticals (CPRX) Notified of Abbreviated New Drug Application Filing for FIRDAPSE

Jan 19, 2023 07:23 AM Catalyst Pharmaceutical Partners (CPRX) PT Raised to $22 at Truist Securities

Dec 21, 2022 07:35 AM Catalyst Pharmaceutical Partners (CPRX) PT Raised to $18 at Truist Securities

Dec 21, 2022 06:43 AM Catalyst Pharmaceutical Partners (CPRX) PT Raised to $24 at H.C. Wainwright

Dec 20, 2022 06:17 AM Catalyst Pharmaceutical Partners (CPRX) PT Raised to $20 at Piper Sandler

Dec 19, 2022 04:10 PM Catalyst Pharmaceuticals (CPRX) to Acquire US Commercial Rights to FYCOMPA CIII From Eisai

Nov 9, 2022 04:37 PM Catalyst Pharmaceuticals (CPRX) Tops Q3 EPS by 8c; Offers FY22 Revenue Guidance

Sep 29, 2022 11:18 AM Catalyst Pharmaceuticals (CPRX) Announces FDA Approval of Supplemental New Drug Application for FIRDAPSE® Expanding Patient Population to Include Pediatric Patients

Sep 13, 2022 08:53 AM Pre-Open Movers: Akero Doubles on Drug Data, Tech Stocks Fall on Hot CPI

Sep 13, 2022 05:53 AM Catalyst Pharmaceuticals (CPRX) to Join S&P SmallCap 600

Sep 12, 2022 05:44 PM After-Hours Movers: Oracle Up on Revenue Beat, Peloton Falls as Co-Founders Resign

Sep 12, 2022 05:16 PM Catalyst Pharmaceuticals (CPRX) to Join SmallCap 600

Aug 24, 2022 05:04 AM Roth Capital Downgrades Catalyst Pharmaceutical Partners (CPRX) to Neutral